Patents by Inventor Ferdinando Maria Milazzo

Ferdinando Maria Milazzo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HDAC INHIBITORS-BASED ANTIBODY DRUG CONJUGATES (ADCs) AND USE IN THERAPY
    Publication number: 20210128740
    Abstract: The present invention relates to novel Histone Deacetylase Inhibitors (HDACi)-based antibody drug conjugates particularly with antibodies directed to ErbB, ErbB2 and ErbB3 receptors, pharmaceutical compositions comprising said antibodies as well as to their use in the treatment of cancer or tumor and other diseases where a modulation of one or more histone deacetylase isoforms can be effective for therapeutic interventions.
    Type: Application
    Filed: March 27, 2018
    Publication date: May 6, 2021
    Applicant: ALFASIGMA S.P.A.
    Inventors: Loredana Vesci, Rita De Santis, Ferdinando Maria Milazzo, Giuseppe Giannini, Maurizio Taddei, Valentina Faltoni, Elena Petricci
  • Use of ?-phenylthiocarboxylic and ?-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
    Patent number: 7375124
    Abstract: The use is described of derivatives of ?-phenylthiocarboxylic and ?-phenyloxycarboxylic acids with formula (i): in which the substituents have the meanings described in the text, for the preparation of a medicine for the prophylaxis and treatment of diabetes, particularly type 2 diabetes, its complications, the various forms of insulin resistance, and hyperlipidaemias
    Type: Grant
    Filed: December 16, 2003
    Date of Patent: May 20, 2008
    Assignee: Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
    Inventors: Fabio Giannessi, Emanuela Tassoni, Maria Ornella Tinti, Pompeo Pessotto, Natalina Dell'Uomo, Anna Floriana Sciarroni, Tiziana Brunetti, Ferdinando Maria Milazzo